Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri A Dubey

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Vaccines|December 23, 2020
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus DiseaseJoan G Tell, Beth-Ann G Coller, Sheri A Dubey, et al.
Frontiers in Immunology|November 19, 2015
Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationJanet J Sei, Kara S Cox, Sheri A Dubey, et al.
Journal of Virology|August 17, 2005
Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservationMark J Geels, Sheri A Dubey, Kiersten Anderson, et al.
Journal of Virology|June 6, 2008
DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profilesKara S Cox, James H Clair, Michael T Prokop, et al.
Current Topics in Microbiology and Immunology|September 18, 2017
Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease OutbreakElizabeth S Higgs, Sheri A Dubey, Beth A G Coller, et al.
Vaccine|November 12, 2015
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigensGokul Swaminathan, Elizabeth A Thoryk, Kara S Cox, et al.
Cellular Immunology|May 17, 2011
Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonistsEkambar R Kandimalla, Mary Struthers, Andrew J Bett, et al.
Ebiomedicine|October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approachBhargava Kandala, Nele Plock, Akshita Chawla, et al.
Plos One|June 23, 2011
Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step studyFusheng Li, Adam C Finnefrock, Sheri A Dubey, et al.
Journal of Virology|March 17, 2017
A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV ChallengeDai Wang, Shannon Phan, Daniel J DiStefano, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Vaccines|December 23, 2020
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus DiseaseJoan G Tell, Beth-Ann G Coller, Sheri A Dubey, et al.
Frontiers in Immunology|November 19, 2015
Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationJanet J Sei, Kara S Cox, Sheri A Dubey, et al.
Journal of Virology|August 17, 2005
Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservationMark J Geels, Sheri A Dubey, Kiersten Anderson, et al.
Journal of Virology|June 6, 2008
DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profilesKara S Cox, James H Clair, Michael T Prokop, et al.
Current Topics in Microbiology and Immunology|September 18, 2017
Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease OutbreakElizabeth S Higgs, Sheri A Dubey, Beth A G Coller, et al.
Vaccine|November 12, 2015
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigensGokul Swaminathan, Elizabeth A Thoryk, Kara S Cox, et al.
Cellular Immunology|May 17, 2011
Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonistsEkambar R Kandimalla, Mary Struthers, Andrew J Bett, et al.
Ebiomedicine|October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approachBhargava Kandala, Nele Plock, Akshita Chawla, et al.
Plos One|June 23, 2011
Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step studyFusheng Li, Adam C Finnefrock, Sheri A Dubey, et al.
Journal of Virology|March 17, 2017
A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV ChallengeDai Wang, Shannon Phan, Daniel J DiStefano, et al.
Pageof 3